Cytokinetics (CYTK) Tops Q4 EPS by 8c
Tweet
Share
E-mailGet Alerts CYTK Hot Sheet
Price: $67.65 +0.13%
Revenue Growth %: +1,966.3%
Financial Fact:
Net loss: 31.89M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Revenue Growth %: +1,966.3%
Financial Fact:
Net loss: 31.89M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Cytokinetics (NASDAQ: CYTK) reported Q4 EPS of ($0.24), $0.08 better than the analyst estimate of ($0.32). Revenue for the quarter came in at $9.8 million versus the consensus estimate of $10.49 million.
For earnings history and earnings-related data on Cytokinetics (CYTK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MillerKnoll, Inc. (MLKN) Tops Q1 EPS by 18c ; Offers Guidance
- ’Not your father’s Sandisk’: Rosenblatt starts coverage at Buy
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
